Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Avadel Pharmaceuticals plc’s current trading price is -52.38% away from its 52-week high, while its distance from the 52-week low is 23.00%. The stock’s price range during this period has varied between $7.39 and $19.09. The company, active in the Healthcare sector, saw a trading volume of around 2.85 million for the day, considerably higher average daily volume of 1.52 million observed over the last three months.
The stock market performance of Avadel Pharmaceuticals plc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $19.09 on 05/03/24, while the lowest price during the same time frame was $7.39, recorded on 01/10/25.
How Financial Performance Impacts Market Capitalization
Avadel Pharmaceuticals plc (AVDL) has experienced a quarterly decline of -40.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 875.91M and boasts a workforce of 154 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.30, with a change in price of -4.72. Similarly, Avadel Pharmaceuticals plc recorded 1,286,355 in trading volume during the last 100 days, posting a change of -34.18%.
How AVDL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AVDL stands at 0.49. Similarly, the long-term debt-to-equity ratio is also 0.48.
AVDL Stock Stochastic Average
As of today, the raw stochastic average of Avadel Pharmaceuticals plc over the last 50 days is at 39.81%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 96.02%. Further, the company’s Stochastic %K and %D values for the last 20 days were 55.42% and 36.25%, respectively.
AVDL Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -13.51%. However, over the past six months, we’ve seen a stronger performance of -42.25%. The price of AVDL leaped by -14.97% over the last 30 days. And in the last five days, it has surged by 14.05%.
